Summary
Physicochemical properties of two types of adriamycin preparation, suspensions and emulsions prepared for i.a. chemotherapy of hepatocellular cacinoma, were investigated. A suspension was prepared by dispersing adriamycin directly into the lipid contrast medium, Lipiodol, whereas an emulsion was obtained by emulsifying an aqueous solution of adriamycin into Lipiodol. The dispersibility of the drug in each preparation was examined microscopically. The chemical stability of and drug release from the preparation were determined by high-performance liquid chromatography and spectrophotometry, respectively. The suspension was then given to ten patients with primary hepatocellular carcinoma. The suspension maintained good dispersibility without coagulation of drug particles, whereas coalescence of aqueous droplets and the resultant phase separation occurred 4 h after preparation of the emulsion. Both preparations maintained the initial drug content for at least 1 week at room temperature. The release of adriamycin was more prolonged in the suspension than in the emulsion. After i.a. administration of the suspension, a selective accumulation of Lipiodol in the tumor and decrease in serum α-fetoprotein (AFP) levels were found in most patients. A significant amount of adriamycin was still detected in hepatic speciments resected from two patients 1 and 2 months after treatment. These findings suggest that the adriamycin-Lipiodol suspension may be a useful preparation for targeting chemotherapy to hepatocellular carcinoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fujimoto S, Endoh F, Kitsukawa Y, Okui K, Morimoto Y, Sugibayashi K, Miyakawa A, Suzuki H (1983) Continued in vitro and in vivo release of an anticancer drug from albumin microspheres. Experientia 39: 913
Fukushima S, Juni K, Nakano M (1983) Preparation and drug release from W/O/W type double emulsions containing anticancer agents. Chem Pharm Bull 31: 4048
Idezuki Y, Sugiura M, Hatano S, Kimoto S (1966) Hepatography for detection of small tumor masses in liver: experiences with oily contrast medium. Surgery 60: 566
Juni K, Ogata J, Nakano M, Ichihara T, Mori K, Akagi M (1985) Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing doxorubicin. Chem Pharm Bull 33: 313
Kanematsu T, Inokuchi K, Sugimachi K, Furuta T, Sonoda T, Tamura S, Hasuo K (1984) Selective effects of Lipiodolized antitumor agents. J Surg Oncol 25: 218
Konno T, Maeda H, Yokoyama I, Iwai K, Ogata K, Tashiro S, Uemura K, Mochinaga M, Watanabe E, Nakakuma K, Morinaga T, Miyauchi Y (1982) Use of a lipid lymphographic agent, Lipiodol, as a carrier of high molecular weight antitumor agent, SMANCS, for hepatocellular carcinoma. Jpn J Cancer Chemother 9: 2005
Konno T, Tashiro S, Maeda H, Iwai K, Ogata K, Mochinaga M, Uemura K, Ishimaru S, Miyauchi Y, Yokoyama I (1983) Treatment of hepatoma with intraarterial administration of oily anticancer agent. Jpn J Cancer Chemother 10: 351
Konno T, Maeda H, Iwai K, Tashiro S, Maki S, Morinaga T, Mochinaga M, Hiraoka T, Yokoyama I (1983) Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report. Eur J Clin Oncol 19: 1053
Lee YT N, Chan KK, Harris PA, Cohen JL (1980) Distribution of adriamycin in cancer patients: tissue uptake, serum concentration after IV and hepatic IA administration. Cancer 45: 2231
Masuike T, Odake J, Kohagura H, Noda T, Takemoto Y (1984) Determination of adriamycin and its metabolites in biological samples using high performance liquid chromatography: II. Analysis of tissues by extraction method. Yakugaku Zasshi 104: 620
McIntire KR, Vogel CL, Primack A, Waldmann TA, Kyalwazi SK (1976) Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma. Cancer 37: 677
Miyazaki S, Ishii K, Sugibayashi K, Morimoto Y, Takada M (1982) Antitumor effect of ethylene-vinyl acetate copolymer containing 5-fluorouracil on Ehrlich ascites carcinoma. Chem Pharm Bull 30: 3770
Nagasue N, Inokuchi K, Kobayashi M, Saku M (1977) Serum alpha-fetoprotein levels after hepatic artery ligation and post-operative chemotherapy. Cancer 40: 615
Seldinger SI (1953) Catheter replacement of needle in percutaneous arteriography: new technique. Acta Radiol 39: 368
Tanigawara Y, Yamaoka K, Nakagawa T, Uno T (1982) New method for the evaluation of in vitro dissolution time and disintegration time. Chem Pharm Bull 30: 1088
Taniguchi H, Yamaguchi T, Takahashi T (1986) Basic study of anti-cancer agents suspended in Lipiodol. Jpn J Cancer Chemother 13: 255
The United States Pharmacopeia XXI (revised) (1985) Official monographs/doxorubicin hydrochloride. United States Pharmacopeial Convention, Inc., Rockville, p 357
Vermess M, Doppman JL, Sugarbaker P, Fisher R, Chatterji DC, Luetzeler J, Grimes G, Girton M, Adamson R (1980) Clinical trials with a new intravenous liposoluble contrast material for computed tomography of the liver and spleen. Radiology 137: 217
Vermess M, Doppman JL, Sugarbaker PH, Fisher RI, O'Leary TL, Chatterjj DC, Grimes G, Adamson RH, Willis M, Edwards BK (1982) Computed tomography of the liver and spleen with intravenous lipoid contrast material: review of 60 examinations. AJR 138: 1063
Yoshioka T, Ikeuchi K, Hashida M, Muranishi S, Sezaki H (1982) Prolonged release of bleomycin from parenteral gelatin sphere-in-oil-in-water multiple emulsion. Chem Pharm Bull 30: 1408
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Katagiri, Y., Mabuchi, K., Itakura, T. et al. Adriamycin-Lipiodol suspension for i. a. chemotherapy of hepatocellular carcinoma. Cancer Chemother. Pharmacol. 23, 238–242 (1989). https://doi.org/10.1007/BF00451648
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00451648